See also this year's filing and all EDGAR filings for this company.
PDF Report 0001557746_2016_Aclaris_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001557746, Aclaris Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 86,524,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 360,000 |
| 3 | remainder_Assets | 7,192,000 |
| 4 | LiabilitiesCurrent | 1,555,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,328,000 |
| 9 | ResearchAndDevelopmentExpense | 15,339,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 104,000 |
| 13 | remainder_ComprehensiveNetIncome | -143,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 94,076,000 |
| 1 | Liabilities | 1,555,000 |
| 2 | Expenses | 20,667,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 92,521,000 |
| 5 | NetIncome | -20,563,000 |
| 6 | ComprehensiveNetIncome | -20,634,500 |
| 7 | BaseVar | 58,272,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.79 |
| 9 | EconomicCapitalRatio | 4.23 |
Edgar->Model Mapping
Feature Distribution
